Bank of Montreal
GENE

Bank of Montreal’s Genetic Technologies Ltd. GENE Stock Holding History

Bank of Montreal’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-750
Closed -$79K – 4147
2015
Q1 		$79K Buy
+750
New +$61.3K ﹤0.01% 2741

Other funds holding GENE

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 27.61% 1-Year Est. Return

Bank of Montreal's GENE Position: Q2 2015 in Review

Bank of Montreal sold out of Genetic Technologies Ltd. (GENE) in Q2 2015, closing a stake of 750 shares — an estimated $79K sold.

Bank of Montreal first reported a position in GENE in Q1 2015 and held it in 1 quarter. The position peaked at $79K in Q1 2015. 8 funds tracked by Wall St. Rank hold GENE as of Q2 2015.

  • Bank of Montreal reported no remaining Genetic Technologies Ltd. position as of Q2 2015 after selling out during the quarter.
  • Bank of Montreal sold 750 Genetic Technologies Ltd. shares in Q2 2015, an estimated $79K.
  • Bank of Montreal first reported a position in Genetic Technologies Ltd. in Q1 2015 and held it in 1 quarter.
  • Bank of Montreal's Genetic Technologies Ltd. position peaked at $79K in Q1 2015.
  • 8 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q2 2015.

Based on Bank of Montreal's 13F filing for Q2 2015, filed 4 Aug 2015.